ARCHIVES

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

This article is from The Cancer Letter archive.

Vol. 36 No. 26 | July 9, 2010

Download PDF Visit The Full Archive

Related Articles

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

DCT Board Okays Concepts For New Radiation Studies

June 12, 1987

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

Arimidex Continues To Show Improvement Over Tamoxifen

December 27, 2002

NCAB, De Vita Rap Tobacco Industry For Targeting Blacks, Hispanics

October 24, 1986

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012